VDI
GILD icon

Vaughan David Investments’s Gilead Sciences GILD Stock Holding History

Vaughan David Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39.6M Buy
284,485
+9,094
+3% +$1.27M 0.84% 62
2025
Q4 		$33.8M Buy
+275,391
New +$33.5M 0.74% 70

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vaughan David Investments's GILD Position: Q1 2026 in Review

Vaughan David Investments increased its Gilead Sciences (GILD) stake by 3.3% in Q1 2026, buying an estimated $1.27M and bringing the position to 284,485 shares worth $39.6M. The position accounts for 0.84% of the portfolio, ranked #62.

Vaughan David Investments first reported a position in GILD in Q4 2025 and has held it in 2 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Vaughan David Investments held 284,485 shares of Gilead Sciences worth $39.6M as of Q1 2026.
  • Vaughan David Investments bought 9,094 Gilead Sciences shares in Q1 2026, an estimated $1.27M.
  • Gilead Sciences made up 0.84% of Vaughan David Investments's portfolio in Q1 2026, its #62 holding.
  • Vaughan David Investments first reported a position in Gilead Sciences in Q4 2025 and has held it in 2 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Vaughan David Investments's 13F filing for Q1 2026, filed 12 May 2026.